Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 9:25 PM UTC
| NCT Number | NCT07872553 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | October 13, 2026 (21 hours ago) |
As of October 13, 2026: Clinical trial NCT07872553 is currently recruiting participants. This early_phase1 study for renal cell carcinoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07872553 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07872553 was last updated 21 hours ago (October 13, 2026). HelloStudys verifies this status automatically.